Catheterization and Cardiovascular Interventions

Cover image for Vol. 79 Issue 6

1 May 2012

Volume 79, Issue 6

Pages 849–1022

  1. President's Page

    1. Top of page
    2. President's Page
    3. Coronary Artery Disease
  2. Coronary Artery Disease

    1. Top of page
    2. President's Page
    3. Coronary Artery Disease
    1. Original Studies

      Quality improvement in the door-to-balloon times for ST-elevation myocardial infarction patients presenting without chest pain (pages 851–858)

      William B. Borden, Michelle M. Fennessy, Anne M. O'Connor, Robert A. Mulliken, Linda Lee, Sandeep Nathan, Jearlyn Nichols and John J. Lopez

      Version of Record online: 12 DEC 2011 | DOI: 10.1002/ccd.23221

    2. Editorial Comment

    3. Original Studies

      Thrombus aspiration alone during primary percutanous coronary intervention as definitive treatment in acute ST-elevation myocardial infarction (pages 860–867)

      Miranda C. Kramer, Niels C. Verouden, Xiaofei Li, Karel T. Koch, Allard C. van der Wal, Jan G. Tijssen and Robbert J. de Winter

      Version of Record online: 10 JAN 2012 | DOI: 10.1002/ccd.23214

    4. Editorial Comment

    5. Original Studies

      Lack of long-term clinical benefit of thrombus aspiration during primary percutaneous coronary intervention with paclitaxel-eluting stents or bare-metal stents: Post-hoc analysis of the PASSION-trial (pages 870–877)

      Maarten A. Vink, Maurits T. Dirksen, Jan G.P. Tijssen, Maarten J. Suttorp, Mark S. Patterson, Nan van Geloven, Alexander J. Ijsselmuiden, Ton Slagboom, Ferdinand Kiemeneij and Gerrit J. Laarman

      Version of Record online: 12 DEC 2011 | DOI: 10.1002/ccd.23226

    6. Editorial Comment

    7. Original Studies

      Proximal and distal maximal luminal diameters as a guide to appropriate deployment of the ABSORB everolimus-eluting bioresorbable vascular scaffold : A Sub-Study of the ABSORB Cohort B and the On-Going ABSORB EXTEND Single Arm Study (pages 880–888)

      Vasim Farooq, Josep Gomez-Lara, Salvatore Brugaletta, Bill D. Gogas, Hector M. Garcìa-Garcìa, Yoshinobu Onuma, Robert Jan van Geuns, Antonio Bartorelli, Robert Whitbourn, Alexandre Abizaid and Patrick W. Serruys

      Version of Record online: 5 OCT 2011 | DOI: 10.1002/ccd.23177

    8. Editorial Comment

    9. Original Studies

      Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold (pages 890–902)

      Josep Gómez-Lara, Salvatore Brugaletta, Roberto Diletti, Bill D. Gogas, Vasim Farooq, Yoshinobu Onuma, Pierre Gobbens, Gerrit Anne Van Es, Hector M. García-García and Patrick W. Serruys

      Version of Record online: 30 NOV 2011 | DOI: 10.1002/ccd.23108

    10. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis (pages 903–909)

      Tarun Chakravarty, Ryan P. Morrissey, Brett Wertman, Jesse Naghi, Stanley Chou, Pavel Goykhman, Niraj Doctor, James Mirocha, James S. Forrester and Raj Makkar

      Version of Record online: 29 JUL 2011 | DOI: 10.1002/ccd.23187

    11. Editorial Comment

    12. Original Studies

      Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts (pages 912–918)

      Sjoerd T. Nauta, Nicolas M. Van Mieghem, Michael Magro, Jaap W. Deckers, Cihan Simsek, Robert Jan Van Geuns, Wim J. Van Der Giessen, Peter De Jaegere, Evelyn Regar, Ron T. Van Domburg and Patrick W. Serruys

      Version of Record online: 30 NOV 2011 | DOI: 10.1002/ccd.23145

    13. Editorial Comment

    14. Original Studies

      A randomized trial of intravenous N-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes (pages 921–926)

      Zehra Jaffery, Anil Verma, Christopher J. White, Arthur G. Grant, Tyrone J. Collins, Mark A. Grise, James S. Jenkins, Paul W. McMullan, Rajan A. Patel, John P. Reilly, Stanley N. Thornton and Stephen R. Ramee

      Version of Record online: 30 NOV 2011 | DOI: 10.1002/ccd.23157

    15. Editorial Comment

    16. Original Studies

    17. Editorial Comment

    18. Original Studies

      Effect of invasive strategy on different genders of chinese patients with non-ST-elevation myocardial infarction (pages 946–955)

      Shao-Sung Huang, Ying-Hwa Chen, Tse-Min Lu, Tao-Cheng Wu, Min-Ji Charng, Jaw-Wen Chen, Ju-Pin Pan and Shing-Jong Lin

      Version of Record online: 11 OCT 2011 | DOI: 10.1002/ccd.23166

    19. The effect of pre-hospital glycoprotein IIb–IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI (pages 956–964)

      Renicus S. Hermanides, J. Wouter van Werkum, Jan Paul Ottervanger, Nicoline J. Breet, A.T. Marcel Gosselink, K. Gert van Houwelingen, Jan-Henk E. Dambrink, Christian Hamm, Jurrien M. ten Berg, Arnoud W.J. van 't Hof and On behalf of the Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group

      Version of Record online: 12 DEC 2011 | DOI: 10.1002/ccd.23165

    20. Editorial Comment

    21. Original Studies

    22. The union of Anti-CD34 antibody can improve the performance of drug-eluting stents (pages 972–978)

      Xing-Sheng Yang, Hua-Gang Zhu, Zhan-Jiang Yu, Fang Ren, Yong-Qiang Chen, Xi Wu, Zheng-Cai Zhang, Li-Jie Zhang and Shu-Zheng Lu

      Version of Record online: 8 DEC 2011 | DOI: 10.1002/ccd.23186

    23. Percutaneous left main coronary disease treatment without on-site surgery back-up in patients with acute coronary syndromes : Immediate and 2-year outcomes (pages 979–987)

      Andrea Gagnor, Francesco Tomassini, Enrico Romagnoli, Vincenzo Infantino, Maria Cristina Rosa Brusin, Cristina Maria, Rosario Tripodi, Giuseppe Sangiorgi and Ferdinando Varbella

      Version of Record online: 5 OCT 2011 | DOI: 10.1002/ccd.23225

    24. Editorial Comment

    25. Core Curriculum

    26. Case Reports